| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.29B | $1.15B | $1.20B |
| YoY Revenue Growth % | +11.8% | -3.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $280.9M | $191.1M | $184.9M |
| Operating Margin % | 21.8% | 16.6% | 15.4% |
| Net Income (GAAP) | $113.3M | $78.9M | $93.9M |
| EBITDA (Normalized) | $654.4M | $506.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $269.1M | $200.3M | $279.9M |
| Capital Expenditures (CapEx) | $466.9M | $394.4M | — |
| Free Cash Flow (FCF) | -$197.8M | -$194.1M | $279.9M |
| FCF Margin % | -15.3% | -16.8% | 23.4% |
| Return on Invested Capital (ROIC %) | 6.0% | 5.0% | — |
| Cash & Short-Term Equivalents | $36.7M | $38.5M | — |
| Total Debt (Short + Long Term) | $2.27B | $1.68B | — |
| Total Stockholders' Equity | $1.48B | $1.39B | — |